Pure Global
NCT06149975

Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury

Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury During Acute Hospitalization
Swiss Federal Institute of Technology·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Traumatic Brain Injury
Drug/Device/Intervention
motor-cognitive training
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Swiss Federal Institute of Technology
Location
Saint Gallen, Switzerland
Timeline & enrollment
Phase
N/A
Start date
Nov 20, 2023
End date
Jun 30, 2024
Enrollment
30 participants
Primary outcome

Recruitment rate,Inclusion rate,Attrition rate,Adherence rate,Compliance rate,Security incidents

Summary

The goal of this clinical study is to test feasibility of a motor-cognitive training program
 in patients after mild to severe traumatic brain injury in an acute hospitalization setting.
 
 The intervention is a step-based dual-task training, i.e. patients are presented with step
 patterns that they have to memorize and then execute in the tempo given by a metronome.
 
 Researchers will assess the feasibility of the motor-cognitive training regarding acceptance
 and safety, user evaluation of the training and training performance.

ICD-10 classifications
Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06149975
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06149975 through Pure Global AI's free database. This phase not specified trial is sponsored by Swiss Federal Institute of Technology and is currently Not yet recruiting. The study focuses on Traumatic Brain Injury. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.